Published in Diabetes Res Clin Pract on July 30, 2008
HNF1A gene polymorphisms and cardiovascular risk factors in individuals with late-onset autosomal dominant diabetes: a cross-sectional study. Cardiovasc Diabetol (2009) 0.89
Determining the role of missense mutations in the POU domain of HNF1A that reduce the DNA-binding affinity: A computational approach. PLoS One (2017) 0.76
Molecular diagnosis of maturity onset diabetes of the young in India. Indian J Endocrinol Metab (2013) 0.76
Variants of the HNF1α gene: A molecular approach concerning diabetic patients from southern Brazil. Genet Mol Biol (2012) 0.76
Low serum level of high-sensitivity C-reactive protein in a Japanese patient with maturity-onset diabetes of the young type 3 (MODY3). J Diabetes Investig (2014) 0.75
Identification and functional analysis of c.422_423InsT, a novel mutation of the HNF1A gene in a patient with diabetes. Mol Genet Genomic Med (2016) 0.75
A Single Nucleotide Variant in HNF-1β is Associated with Maturity-Onset Diabetes of the Young in a Large Chinese Family. Iran J Public Health (2016) 0.75
Undiagnosed MODY: Time for Action. Curr Diab Rep (2015) 0.75
Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med (2010) 5.46
Effect of nateglinide on the incidence of diabetes and cardiovascular events. N Engl J Med (2010) 4.38
Effect of cholecalciferol as adjunctive therapy with insulin on protective immunologic profile and decline of residual β-cell function in new-onset type 1 diabetes mellitus. Arch Pediatr Adolesc Med (2012) 1.54
The new adipose tissue and adipocytokines. Curr Diabetes Rev (2006) 1.11
The N363S polymorphism in the glucocorticoid receptor gene is associated with overweight in subjects with type 2 diabetes mellitus. Clin Endocrinol (Oxf) (2003) 1.01
Estimating cardiovascular risk in patients with type 2 diabetes: a national multicenter study in Brazil. Diabetol Metab Syndr (2009) 0.98
Regional differences in clinical care among patients with type 1 diabetes in Brazil: Brazilian Type 1 Diabetes Study Group. Diabetol Metab Syndr (2012) 0.98
The common -866G>A variant in the promoter of UCP2 is associated with decreased risk of coronary artery disease in type 2 diabetic men. Diabetes (2008) 0.96
Genetic and clinical characteristics of maturity-onset diabetes of the young. Diabetes Obes Metab (2005) 0.94
Poor glycaemic control in Brazilian patients with type 2 diabetes attending the public healthcare system: a cross-sectional study. BMJ Open (2013) 0.92
Islet expression of the DNA repair enzyme 8-oxoguanosine DNA glycosylase (Ogg1) in human type 2 diabetes. BMC Endocr Disord (2002) 0.92
Insulin autoimmune syndrome (Hirata disease) as differential diagnosis in patients with hyperinsulinemic hypoglycemia. Pancreas (2006) 0.89
Distribution of HOMA-IR in Brazilian subjects with different body mass indexes. Arq Bras Endocrinol Metabol (2006) 0.89
Metabolic syndrome and insulin resistance in normal glucose tolerant brazilian adolescents with family history of type 2 diabetes. Diabetes Care (2005) 0.89
HNF1A gene polymorphisms and cardiovascular risk factors in individuals with late-onset autosomal dominant diabetes: a cross-sectional study. Cardiovasc Diabetol (2009) 0.89
Algorithm for the treatment of type 2 diabetes: a position statement of Brazilian Diabetes Society. Diabetol Metab Syndr (2010) 0.88
Dysglycemias in pregnancy: from diagnosis to treatment. Brazilian consensus statement. Diabetol Metab Syndr (2010) 0.88
Visfatin, glucose metabolism and vascular disease: a review of evidence. Diabetol Metab Syndr (2010) 0.87
The impact of knowledge about diabetes, resilience and depression on glycemic control: a cross-sectional study among adolescents and young adults with type 1 diabetes. Diabetol Metab Syndr (2013) 0.87
Myocardial dysfunction in mitochondrial diabetes treated with Coenzyme Q10. Diabetes Res Clin Pract (2005) 0.85
Proposed involvement of adipocyte glyceroneogenesis and phosphoenolpyruvate carboxykinase in the metabolic syndrome. Biochimie (2005) 0.85
Glibenclamide unresponsiveness in a Brazilian child with permanent neonatal diabetes mellitus and DEND syndrome due to a C166Y mutation in KCNJ11 (Kir6.2) gene. Arq Bras Endocrinol Metabol (2008) 0.83
Association of ADIPOQ variants, total and high molecular weight adiponectin levels with coronary artery disease in diabetic and non-diabetic Brazilian subjects. J Diabetes Complications (2012) 0.83
Heterogeneous behavior of lipids according to HbA1c levels undermines the plausibility of metabolic syndrome in type 1 diabetes: data from a nationwide multicenter survey. Cardiovasc Diabetol (2012) 0.83
Association of circulating levels of nicotinamide phosphoribosyltransferase (NAMPT/Visfatin) and of a frequent polymorphism in the promoter of the NAMPT gene with coronary artery disease in diabetic and non-diabetic subjects. Cardiovasc Diabetol (2013) 0.82
Fibrinolytic dysfunction after gestation is associated to components of insulin resistance and early type 2 diabetes in latino women with previous gestational diabetes. Diabetes Res Clin Pract (2007) 0.82
The effectiveness of a non-pharmacological intervention for weight gain management in severe mental disorders: results from a national multicentric study. Rev Bras Psiquiatr (2011) 0.81
Association of lipoprotein lipase D9N polymorphism with myocardial infarction in type 2 diabetes: the genetics, outcomes, and lipids in type 2 diabetes (GOLD) study. Atherosclerosis (2008) 0.81
Open-flap versus flapless esthetic crown lengthening: 12-month clinical outcomes of a randomized controlled clinical trial. J Periodontol (2013) 0.80
Estimation of diabetes risk in Brazilian population by typing for polymorphisms in HLA-DR-DQ, INS and CTLA-4 genes. Dis Markers (2005) 0.80
Influence of the polymorphisms Tpr64Arg in the beta 3-adrenergic receptor gene and Pro12Ala in the PPAR gamma 2 gene on metabolic syndrome-related phenotypes in an indigenous population of the Brazilian Amazon. Diabetes Care (2004) 0.80
Atypical generalized lipoatrophy and severe insulin resistance due to a heterozygous LMNA p.T10I mutation. Arq Bras Endocrinol Metabol (2008) 0.80
ADIPOQ and adiponectin: the common ground of hyperglycemia and coronary artery disease? Arq Bras Endocrinol Metabol (2011) 0.80
Expression of phosphoenolpyruvate carboxykinase gene in human adipose tissue: induction by rosiglitazone and genetic analyses of the adipocyte-specific region of the promoter in type 2 diabetes. Biochimie (2003) 0.80
A 6-month randomized controlled trial to test the efficacy of a lifestyle intervention for weight gain management in schizophrenia. BMC Psychiatry (2013) 0.80
[Cardiovascular disease and diabetes]. Arq Bras Endocrinol Metabol (2007) 0.79
HDL cholesterol levels and weight are the main determinants of subclinical atherosclerosis in the young with type 1 diabetes and suitable glycaemic control. Diab Vasc Dis Res (2014) 0.79
Relationship between adherence to diet, glycemic control and cardiovascular risk factors in patients with type 1 diabetes: a nationwide survey in Brazil. Nutr J (2014) 0.79
Unusual occurrence of intestinal pseudo obstruction in a patient with maternally inherited diabetes and deafness (MIDD) and favorable outcome with coenzyme Q10. Arq Bras Endocrinol Metabol (2008) 0.79
Major components of metabolic syndrome and adiponectin levels: a cross-sectional study. Diabetol Metab Syndr (2014) 0.79
[Type 2 Diabetes in children and adolescents: literature review]. J Pediatr (Rio J) (2003) 0.78
Relationship between glycated hemoglobin and metabolic syndrome of type 1 and type 2 diabetes: a factor analysis study. Diabetes Care (2010) 0.78
Genetics of macrovascular complications in diabetes. Curr Diab Rep (2006) 0.78
Diagnosis of hyperglycemia in a cohort of Brazilian subjects: fasting plasma glucose- and oral glucose tolerance test-based glycemic status are associated with different profiles of insulin sensitivity and insulin secretion. Diabetes Care (2007) 0.77
[Cardiovascular assessment of diabetic patients]. Arq Bras Endocrinol Metabol (2007) 0.77
Aerobic exercise capacity and pulmonary function in athletes with and without type 1 diabetes. Diabetes Care (2010) 0.77
Adiponectin gene and cardiovascular risk in type 2 diabetic patients: a review of evidences. Arq Bras Endocrinol Metabol (2007) 0.77
[Non-pharmacological interventions for weight gain in patients with schizophrenia taking antipsychotics]. Arq Bras Endocrinol Metabol (2009) 0.77
[Continuous glucose monitoring: a critical appraisal after one year experience]. Arq Bras Endocrinol Metabol (2006) 0.76
[Metabolic alterations in HIV-associated lipodystrophy syndrome]. Arq Bras Endocrinol Metabol (2006) 0.75
Role of the Gly40Ser mutation in the glucagon receptor gene in Brazilian patients with type 2 diabetes mellitus. Pancreas (2002) 0.75
Prevalence of GAD autoantibodies in Brazilian women with previous gestational diabetes. Diabetes Res Clin Pract (2007) 0.75
Evolving metformin treatment strategies in type-2 diabetes: from immediate-release metformin monotherapy to extended-release combination therapy. Am J Ther (2014) 0.75
A 12-wk follow-up study to evaluate the effects of mixing insulin lispro and insulin glargine in young individuals with type 1 diabetes. Pediatr Diabetes (2012) 0.75
Antipsychotic drugs and metabolic syndrome--can we prevent it? Rev Bras Psiquiatr (2007) 0.75
A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk. Am J Cardiol (2013) 0.75
Cross-reactivity of new insulin analogs in insulin assays. Arq Bras Endocrinol Metabol (2007) 0.75